Loading…
5 companies · GEL, thousands · columns ordered by revenue
GEL, thousands · money Σ · ratios from summed bases · growth on the pooled series
| Metric | FY 2023 |
|---|---|
| Revenue | 214,999 |
| EBITDA | 58,671 |
| Net profit | 57,768 |
| Total assets | 176,227 |
| n (companies reporting) | 5 |
GEL, thousands
| Company | FY 2023 |
|---|---|
| CIS Pharma | 48,230 |
| Gea | 44,821 |
| Ivermedi | 47,124 |
| Welfare International | 29,690 |
| Mermisi | 45,135 |
Rows are the raw pool — every peer, including any excluded from the sums above, so the de-duplication stays auditable. Tinted cells are the excluded company-years.
Pooled figures sum every peer in the set. Known parent/subsidiary groups that file separately are de-duplicated; groups not yet curated may still be counted more than once.